STOCK TITAN

PROCEPT BioRobotics (PRCT) CEO adds 23,900 shares via trust purchase

(High)
(Positive)
Form Type
4

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp reported that President and CEO Larry L. Wood, through The Larry Wood Trust, purchased 23,900 shares of common stock on August 7, 2026 at a weighted average price of $20.85 per share, with individual trade prices ranging from $20.67 to $21.02. Following this transaction, the trust holds 23,900 shares indirectly, and Wood also holds 314,203 shares directly, which include 825 shares acquired on May 14, 2026 under the company’s 2021 Employee Stock Purchase Plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Wood Larry L
Role President, CEO
Bought 23,900 shs ($498K)
Type Security Shares Price Value
Purchase Common Stock F1 23,900 $20.85 $498K
holding Common Stock F2 -- -- --
Holdings After Transaction: Common Stock — 23,900 shares (Indirect, The Larry Wood Trust); Common Stock — 314,203 shares (Direct)
Footnotes (2)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.67 to $21.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. F2. Includes 825 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan.
Shares purchased 23,900 shares Common stock bought on August 7, 2026 by The Larry Wood Trust
Weighted average purchase price $20.85 per share Average price for the 23,900-share purchase, with trades between $20.67 and $21.02
Indirect holdings after transaction 23,900 shares Common stock held indirectly through The Larry Wood Trust after the purchase
Direct holdings after transaction 314,203 shares Common stock held directly by Larry L. Wood, including 825 ESPP shares
ESPP shares included 825 shares Shares acquired on May 14, 2026 under the 2021 Employee Stock Purchase Plan
Purchase price range $20.67–$21.02 per share Range of individual trade prices for the 23,900-share purchase
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Purchase Plan financial
"Includes 825 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
indirect financial
"total_shares_following_transaction 23,900.0000, direct_or_indirect I, nature_of_ownership The Larry Wood Trust"
open market or private transaction financial
"transaction_code_description Purchase in open market or private transaction"

FAQ

What insider purchase did PROCEPT BioRobotics (PRCT) report for Larry L. Wood?

Larry L. Wood’s trust purchased 23,900 PRCT shares on August 7, 2026. The shares were bought at a $20.85 weighted average price, in multiple trades between $20.67 and $21.02 per share.

At what price did the PROCEPT BioRobotics (PRCT) CEO buy shares?

The CEO’s trust bought shares at a $20.85 weighted average price. Individual transactions occurred in a price range from $20.67 to $21.02 per PRCT share, as disclosed in the trade footnote.

How many PROCEPT BioRobotics (PRCT) shares does Larry L. Wood now own directly?

Larry L. Wood directly owns 314,203 PRCT shares after the reported transactions. This direct position includes 825 shares acquired on May 14, 2026 through PROCEPT BioRobotics’ 2021 Employee Stock Purchase Plan.

How many PROCEPT BioRobotics (PRCT) shares are held indirectly for the CEO?

The Larry Wood Trust holds 23,900 PRCT shares indirectly for Larry L. Wood. These shares were purchased on August 7, 2026 in open-market or private transactions at prices between $20.67 and $21.02 per share.

What does the PROCEPT BioRobotics (PRCT) filing say about the trade price range?

The filing reports a weighted average price of $20.85 for the 23,900-share purchase. It notes that trades were executed across a $20.67–$21.02 range and that detailed per-trade pricing is available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wood Larry L

(Last)(First)(Middle)
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE

(Street)
SAN JOSE CALIFORNIA 95134

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026P23,900A$20.85(1)23,900IThe Larry Wood Trust
Common Stock314,203(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.67 to $21.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
2. Includes 825 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan.
Remarks:
/s/ Jonathan Stone, as Attorney-in-Fact for Larry Wood08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)